Literature DB >> 17467818

MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour.

Maggie K-L Fung1, Hiu-Wing Cheung, Hing-Lok Wong, Hiu-Fung Yuen, Ming-Tat Ling, Kowk-Wah Chan, Yong-Chuan Wong, Annie L-M Cheung, Xianghong Wang.   

Abstract

Chromosomal instability (CIN) is a common characteristic in testicular germ cell tumour (TGCT). A functional mitotic checkpoint control is important for accurate chromosome segregation during mitosis. Mitotic arrest deficient 2 (MAD2) is a key component of this checkpoint and inactivation of MAD2 is correlated with checkpoint impairment. The aim of this study was to investigate the function of mitotic checkpoint control in TGCT cells and to study its association with MAD2 expression using 8 TGCT cell lines as well as 23 TGCT tissue samples. We found that in response to microtubule disruption, 6 of 8 TGCT cell lines (75%) failed to arrest in mitosis demonstrated by the decreased mitotic index and aberrant expression of mitosis regulators, indicating that mitotic checkpoint defect is a common event in TGCT cells. This loss of mitotic checkpoint control was correlated with reduced MAD2 protein expression in TGCT cell lines implicating that downregulation of MAD2 may play a critical role in an impaired mitotic checkpoint control in these cells. In addition, immunohistochemistry studies on 23 seminomas and 12 normal testis tissues demonstrated that nuclear expression of MAD2 was much lower in seminomas (p<0.0001) but cytoplasmic MAD2 expression was higher in seminomas (p=0.06) than normal samples. Our results suggest that aberrant MAD2 expression may play an essential role in a defective mitotic checkpoint in TGCT cells, which may contribute to CIN commonly observed in TGCT tumours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467818     DOI: 10.1016/j.bbamcr.2007.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  MTBP plays a crucial role in mitotic progression and chromosome segregation.

Authors:  N Agarwal; Y Tochigi; A S Adhikari; S Cui; Y Cui; T Iwakuma
Journal:  Cell Death Differ       Date:  2011-01-28       Impact factor: 15.828

Review 2.  Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.

Authors:  A Ogden; P C G Rida; R Aneja
Journal:  Cell Death Differ       Date:  2012-06-01       Impact factor: 15.828

3.  Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors.

Authors:  Espen Burum-Auensen; Rolf I Skotheim; Aasa R Schjølberg; Jo Røislien; Ragnhild A Lothe; Ole Petter F Clausen
Journal:  J Carcinog       Date:  2010-03-04

4.  Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.

Authors:  Fiona Furlong; Patricia Fitzpatrick; Sharon O'Toole; Sine Phelan; Barbara McGrogan; Aoife Maguire; Anthony O'Grady; Michael Gallagher; Maria Prencipe; Aloysius McGoldrick; Paul McGettigan; Donal Brennan; Orla Sheils; Cara Martin; Elaine W Kay; John O'Leary; Amanda McCann
Journal:  J Pathol       Date:  2012-01-17       Impact factor: 7.996

5.  MAD2 Expression in Ovarian Carcinoma: Different Expression Patterns and Levels among Various Types of Ovarian Carcinoma and Its Prognostic Significance in High-Grade Serous Carcinoma.

Authors:  Po Eun Park; Ji Yun Jeong; Sun Zoo Kim; Ji Young Park
Journal:  Korean J Pathol       Date:  2013-10-25

6.  Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.

Authors:  Ana Vanessa Nascimento; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Mol Pharm       Date:  2014-09-26       Impact factor: 4.939

7.  The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Authors:  Tara Byrne; Helen G Coleman; Janine A Cooper; W Glenn McCluggage; Amanda McCann; Fiona Furlong
Journal:  Oncotarget       Date:  2017-06-08

8.  Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.

Authors:  M Prencipe; P Fitzpatrick; S Gorman; M Tosetto; M Mosetto; R Klinger; F Furlong; M Harrison; D O'Connor; I B Roninson; J O'Sullivan; A McCann
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

9.  A mitotic kinase scaffold depleted in testicular seminomas impacts spindle orientation in germ line stem cells.

Authors:  Heidi Hehnly; David Canton; Paula Bucko; Lorene K Langeberg; Leah Ogier; Irwin Gelman; L Fernando Santana; Linda Wordeman; John D Scott
Journal:  Elife       Date:  2015-09-25       Impact factor: 8.140

10.  MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.

Authors:  Alejandro López-Saavedra; Miguel Ramírez-Otero; José Díaz-Chávez; Rodrigo Cáceres-Gutiérrez; Monserrat Justo-Garrido; Marco A Andonegui; Julia Mendoza; Ángela Downie-Ruíz; Carlo Cortés-González; Nancy Reynoso; Clementina Castro-Hernández; Guadalupe Domínguez-Gómez; Miguel Santibáñez; Eunice Fabián-Morales; Franz Pruefer; Fernando Luna-Maldonado; Rodrigo González-Barrios; Luis A Herrera
Journal:  Cell Cycle       Date:  2016-06-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.